Pretty significant news, all of a sudden there are potential multiple revenue streams from lymphedema, heart and renal. Could be a cash cow in 2022.... current MC pretty cheap given the potential, I just hope we don't get taken over beforehand because the hawks must be circling.
- Forums
- ASX - By Stock
- IPD
- Ann: FDA Grants Breakthrough Device Designation for Renal Failure
Ann: FDA Grants Breakthrough Device Designation for Renal Failure, page-4
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IPD (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $117.3M |
Open | High | Low | Value | Volume |
5.8¢ | 5.8¢ | 5.7¢ | $24.84K | 428.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 162253 | 5.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.9¢ | 586841 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 162253 | 0.058 |
2 | 260016 | 0.057 |
4 | 698381 | 0.055 |
2 | 551851 | 0.054 |
2 | 260000 | 0.053 |
Price($) | Vol. | No. |
---|---|---|
0.059 | 586841 | 3 |
0.060 | 243829 | 3 |
0.062 | 250008 | 1 |
0.063 | 100000 | 1 |
0.064 | 450000 | 2 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
IPD (ASX) Chart |